CONMED Corporation CNMD
NYSE
| 09/30/2026 | 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | |
|---|---|---|---|---|---|
| Revenue | 335.56M | 343.49M | 317.05M | 373.20M | 337.93M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 335.56M | 343.49M | 317.05M | 373.20M | 337.93M |
| Cost of Revenue | 154.91M | 139.13M | 133.60M | 184.51M | 152.11M |
| Gross Profit | 180.65M | 204.36M | 183.45M | 188.69M | 185.82M |
| SG&A Expenses | 132.71M | 138.57M | 133.48M | 134.42M | 133.50M |
| Depreciation & Amortization | -- | -- | -- | -- | -- |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 303.21M | 293.20M | 283.41M | 333.83M | 299.51M |
| Operating Income | 32.35M | 50.29M | 33.64M | 39.37M | 38.42M |
| Income Before Tax | 26.01M | 31.35M | 18.36M | 29.25M | 4.27M |
| Income Tax Expenses | 6.21M | 8.28M | 4.53M | 12.51M | 1.41M |
| Earnings from Continuing Operations | 19.80M | 23.07M | 13.83M | 16.74M | 2.86M |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -- | -- | -- | -- | -- |
| Net Income | 19.80M | 23.07M | 13.83M | 16.74M | 2.86M |
| EBIT | 32.35M | 50.29M | 33.64M | 39.37M | 38.42M |
| EBITDA | 51.53M | 69.34M | 52.47M | 57.02M | 57.03M |
| EPS Basic | 0.66 | 0.77 | 0.45 | 0.54 | 0.09 |
| Normalized Basic EPS | 0.44 | 0.94 | 0.54 | 0.64 | 0.62 |
| EPS Diluted | 0.66 | 0.77 | 0.45 | 0.54 | 0.09 |
| Normalized Diluted EPS | 0.44 | 0.94 | 0.54 | 0.64 | 0.62 |
| Average Basic Shares Outstanding | 29.93M | 30.07M | 30.59M | 30.97M | 30.96M |
| Average Diluted Shares Outstanding | 30.13M | 30.12M | 30.62M | 31.03M | 31.05M |
| Dividend Per Share | -- | -- | -- | 0.00 | 0.20 |
| Payout Ratio | -- | -- | -- | 36.99% | 216.47% |